Leading a Culture of Innovation
Practices
Diligence is the Hallmark of Our Services
Recent News
Read written Recent News About IP and Technology
Financial Post
2024
Ipsen receives its second Shingo Prize for operational excellence
Ipsen is the first pharma company in the world to receive Shingo Prizes for two sites producing treatments for patients Ipsen’s first Shingo Prize was received by its production site in Signes, France in 2020, followed by the site in Dublin, Ireland today The…...
Read MoreGlobeNewswire
2024
Ipsen receives its second Shingo Prize for operational excellence
PARIS, FRANCE, 14 October 2024 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that its Dublin, Ireland production site has received the Shingo Prize for operational excellence. This is Ipsen’s second Shingo Prize, with its site in Signes, France, receivi…...
Read MoreGlobeNewswire
2024
Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24)
Longeveron Lomecel-B data in Alzheimer's disease selected for late breaking poster presentation at Clinical Trials on Alzheimer’s Disease Conf (CTAD24)....
Read MoreInvesting.com
2024
Wells Fargo sets Equal Weight rating on Shoals Technologies shares
Wells Fargo sets Equal Weight rating on Shoals Technologies shares...
Read More
GlobeNewswire
2024
VoIP-Pal Voluntarily Withdraws Recently Filed Complaints in Western Texas Against Verizon and T-Mobile to Focus on Stronger Antitrust Path
WACO, Texas, Oct. 14, 2024 (GLOBE NEWSWIRE) -- VoIP-Pal.com Inc. (“VoIP-Pal” or the “Company”) (OTCQB: VPLM) announces that it has voluntarily withdrawn its two recently filed federal patent litigation complaints in the Western District of Texas against Veriz…...
Read MoreGlobeNewswire
2024
Unicycive Therapeutics Announces Late-Breaker Poster Presentation on Oxylanthanum Carbonate (OLC) at the American Society of Nephrology (ASN) Kidney Week 2024
LOS ALTOS, Calif., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company” or “Unicycive”), today announced that a poster presen…...
Read MoreOur Insights
Insight, Story & Blog
Running a Law Firm on Open Source Technology: Embracing Efficiency and Cost-Effectiveness
Read More
Design Patents vs. Trade Dress Protection for Product Configurations: A Comprehensive Analysis
Read More
Corporate Structuring and Running Multiple Businesses: A Deep Dive into Holding, Operating, and Parent Companies
Read More
Navigating the Capital Raising Maze: A Comprehensive Guide for Startups and Small Businesses
Read More
A Comprehensive Guide to Alternative Dispute Resolution
Read MoreGet in Touch
Ready to work
together? Let's go!
MC Law loves hearing from you. Send us a message to inquire how we can solve your legal issues.
Phone: +1 202.409.1003
Email: contact@mclaw.io
Professionals
OFFICES
PROFESSIONALS
OFFICES
